Success With Islet Autotransplantation for Pancreatic Neoplasia Using a Careful Approach

Melena D. Bellin
DOI: https://doi.org/10.1097/tp.0000000000005050
2024-08-23
Transplantation
Abstract:In this issue of Transplantation , Piemonti et al 1 presented their 15 y of experience with islet autotransplantation (IAT) at the time of total/completion or partial pancreatectomy under their protocol developed at San Raffaele in Milan, Italy. What is particularly unique regarding the experience of the Milan group is that pancreatectomy with IAT was performed for chronic pancreatitis (CP) only in a few cases. The majority of their surgical cohort underwent total pancreatectomy (TP), salvage pancreatectomy, or extended distal pancreatectomy with IAT for pancreatic tumors or neoplasia. IAT was first performed in 1977 in a patient undergoing TP for CP, and in the majority of cases in the United States and elsewhere in the world, the indication for IAT remains recurrent acute or CP and rarely other benign diseases (eg, trauma). 2 , 3 In the United States, IAT is avoided if benign tumors or malignant neoplasia are present because of the concern of inadvertently causing liver metastasis through an infusion of isolated pancreatic tissue. 4
immunology,surgery,transplantation
What problem does this paper attempt to address?